1.06574

七水合磷酸氢二钠

EMPROVE^® ESSENTIAL, DAC, USP

• 同義詞: 磷酸钠 二元 七水合物, 磷酸氢二钠, 磷酸氢二钠 七水合物
• 線性公式: Na₂HPO₄ · 7H₂O
• CAS號碼: 7782-85-6
• 分子量：: 268.07
• MDL號碼: MFCD00149180
• 分類程式碼代碼: 12352302
• 酶委員會索引編號: 231-448-7

屬性

• agency: DAC; USP
• 品質等級: 500
• 蒸汽密度: 4.9 (vs air)
• 產品線: EMPROVE^® ESSENTIAL
• 形狀: solid
• pH值: 8.7-9.3 (25 °C, 50 g/L in H₂O)
• mp: 48 °C (Elimination of water of crystallisation)
• 溶解度: 154 g/L
• 密度: 1.68 g/mL at 25 °C (lit.)
• 應用: liquid formulation; ophthalmics; pharmaceutical; semi-solid formulation; solid formulation
• 儲存溫度: 2-30°C
• SMILES 字串: O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O
• InChI: 1S/2Na.H3O4P.7H2O/c;;1-5(2,3)4;;;;;;;/h;;(H3,1,2,3,4);7*1H2/q2*+1;;;;;;;;/p-2
• InChI 密鑰: PYLIXCKOHOHGKQ-UHFFFAOYSA-L

描述

一般說明

Finding the right excipient that matches your needs as well as regulatory demands can be a complicated challenge. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our Emprove^® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC^® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

di-Sodium hydrogen phosphate heptahydrate is typically used as a phosphate buffer system component for biomolecule downstream chromatography steps or final liquid formulation.

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 儲存類別代碼: 13 - Non Combustible Solids
• 水污染物質分類（WGK）: WGK 1
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable